Subject: Smallcap Discoveries: Weekly Update - March - 14 -18

March - 14 - 18

Market Commentary

Rally time!


This past week all three major North American markets celebrated Saint Patrick's Day by trading and closing well into the green. The Dow ended the week up 5.5%, Nasdaq was up 8.2% and while the TSX was up only 1.7% it hit a new all time high on Friday. Markets rallied strongly as reduced nervousness and no more guessing about rate increases allowed investors to place their market bets with a bit more confidence. The U.S. central bank finally acted on Wednesday to launch a new monetary cycle, with its first rate hike since the end of 2018. As some expected, the hike was for the minimum quarter point instead of a half point as some others had feared. Raising rates reduces the money supply in circulation and, theoretically, calms inflation.


Life science investors also felt the luck of the Irish as the XBI ETF rallied by a solid 8.9% from last week's close and up 14.7% from it's 52 week low reached this past Wednesday. Many of the smaller US listed life science companies we follow had very strong rallies. Let's see if this rally has staying power as the index has been looking for a bottom and is still down 37.9% from exactly one year ago. One question we were asking this week is if the Covid trade might be coming back. A number of countries have been relaxing Covid restrictions at the same time that countries like China and South Korea are seeing large spikes in cases with Hong Kong and Shenzhen now in Covid lockdowns. Even countries like Austria and England, who have recently removed restrictions, are seeing big spikes in cases. As many experts have warned, Covid is far from over.


Last week it was nickel, this week urea? Fertilizer prices climbed to a fresh record, as sales from Russia (one of the world's top producers) are disrupted, and super-expensive natural gas in Europe curtails output. Urea prices hit all time highs on Friday.


As we mentioned last week, food shortages and prices will become very hot topics as food and fertilizer disruptions continue.


Oil finally dipped below $100 before rallying to close around $105. We've been waiting for this dip and oil is now down about 30% from the recent highs allowing us to feel a bit more comfortable adding small amounts of some energy names. Supply remains tight, prompting the International Energy Agency (IEA) to urge OPEC countries to significantly increase production at their next monthly summit. For the time being, the cartel remains unmoved by this type of demand and is sticking to its roadmap of gradually lifting production quotas. We are also seeing more calls on North American producers to increase production. Some of the original activists that once called for more energy company share buybacks are now calling for more production, read more here: https://oilprice.com/Latest-Energy-News/World-News/Activist-Investor-Engine-No-1-Founder-Urges-More-US-Shale-Production.html



And lastly we wanted to let everyone know that another financing will soon be available to subscribers. Alchemy Nanotechnology will be raising $5 million in their going public offering. We will have much more information available soon but in the meantime you can find out more at their website https://alchemynano.com/

Buys and Sells This Week

-Bought IPA.V @ $4.90

-Bought WRG.T at $0.47

Smallcap Discoveries


Select Portfolio

iFabric (TSX: IFA) Price - $3.00 Market Cap - $89M


ImmunoPrecise Antibodies (TSX.V: IPA) Price - $5.67 Market Cap - $112M

  • IPA Selected to Work with Elektrofi on COVID-19 Therapeutic Delivery and Future Pandemic Preparation under SBIR Contract from Defense Health Agency within US Department of Defense

  • Press Release https://tinyurl.com/yazyjd3p

  • ImmunoPrecise Reports Financial Results and Recent Business Highlights for Third Quarter Fiscal Year 2022

  • Revenue of $4.8M

  • Gross profit of $2.58M

  • Net loss of ($3.8M)

  • Press Release https://tinyurl.com/ynmt3v45


We came away very pleased with the news that IPA has partnered with Elektrofi, a company with US Department of Defense funding for a Covid-19 therapeutic. In our opinion this has significantly de-risked the Polytope program and subject to continued good data could dramatically reduce the company funding requirements for their Covid-19 programs. We also saw a sizable cross of shares (approximately 370,000 @ $4.80) which likely takes away the bulk of any warrant selling overhang. The stock rallied nicely off the 52 week low ($4.52) it hit on Monday. We covered a lot more on our most recent free-for-all. We were buyers this past week and believe the company offers a very strong risk/reward opportunity for risk tolerant investors. 


RIWI Corp (TSX.V: RIWI) Price - $0.99 Market Cap - $18M

Smallcap Discoveries


Select Watchlist

Adcore (TSX.V: ADCO) Price - $0.46 Market Cap - $29M

  • Adcore Reports 57% Increase in 2021 Revenue and 356% YoY Increase in Operating Profit in Q4

  • Q4 Revenue of $7.19M

  • Q4 Gross profit of $2.38M

  • Q4 Net income of $588K

  • FY Revenue of $27.9M

  • FY Gross profit of $8.4M

  • FY Net loss of ($277K)

  • Press Release https://tinyurl.com/2p93erdr


Smart Employee Benefits (TSX.V: SEB) Price - $0.25 Market Cap - $43M


Gatekeeper Systems (TSX.V: GSI) Price - $0.455 Market Cap - $41.5M


INEO Tech (TSX.V: INEO) Price - $0.26 Market Cap - $15.6M


Char Technologies (TSX.V: YES) Price - $0.50 Market Cap - $41.5M


Divergent Energy Services (TSX.V: DVG) Price - $0.125 Market Cap - $4M

  • DIVERGENT Energy Services Announces the Release of 2021 Year End Results

  • Q4 Revenue of $2.4M

  • Q4 Adj. EBITDA of $165K

  • Q4 Net loss of ($41K)

  • FY Revenue of $8.36M

  • FY Gross profit of $2M

  • FY Operating income of $397K

  • FY Adj. EBITDA $767K

  • FY Net income of $2.48M

  • Press Release https://tinyurl.com/2p8w2j78


Cipher Pharmaceuticals (TSX.V: CPH) Price - $2.44 Market Cap - $64M

  • Cipher Pharmaceuticals Reports Fourth Quarter and Full Year 2021 Financial Results

  • Q4 Revenue $5.9M

  • Q4 Adj. EBITDA $4.1M

  • Q4 Net income $2.8M

  • FY Revenue of $21.9M

  • FY EBITDA of $11.8M

  • FY Adj. EBITDA of $13.9M

  • FY Net income of $7.7M

  • Press Release https://tinyurl.com/3v3s2zp9


IBEX Technologies (TSX.V: IBT) Price - $0.49 Market Cap - $12M


Wishpond Technologies (TSX.V: WISH) Price - $1.09 Market Cap - $56.5M

Company Interviews & Updates

Upcoming

No meetings this week, Paul is out of town.

Recent

If you missed the last email, or need access to any Smallcap Discoveries tools, be sure to check out the website

Don't forget to follow us on social media!


Powered by:
GetResponse